{
    "ticker": "RANI",
    "name": "Rani Therapeutics Holdings, Inc.",
    "description": "Rani Therapeutics Holdings, Inc. is a biopharmaceutical company focused on the development of innovative drug delivery systems. Founded in 2014, Rani is pioneering a groundbreaking oral delivery platform that enables the administration of biologic drugs, which traditionally require injections, in a non-invasive manner. The company's flagship product is the Rani Pill, a capsule designed to safely and effectively deliver large molecules, such as peptides and proteins, via the gastrointestinal tract. This innovative approach aims to improve patient compliance by eliminating the need for needles and injections, thus transforming the treatment landscape for chronic diseases such as diabetes and other conditions requiring regular medication. Rani's technology has the potential to expand the accessibility of biologic therapies, making them easier and more convenient for patients. The company is committed to advancing its proprietary platform through strategic partnerships, rigorous research, and clinical trials, establishing itself as a leader in the field of oral biologic therapies. Rani\u2019s vision is to enhance the quality of life for patients by providing safer, more effective, and patient-friendly treatment options.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Jose, California, USA",
    "founded": "2014",
    "website": "https://www.ranitherapeutics.com",
    "ceo": "Mir Imran",
    "social_media": {
        "twitter": "https://twitter.com/RaniTherapeutics",
        "linkedin": "https://www.linkedin.com/company/rani-therapeutics"
    },
    "investor_relations": "https://ir.ranitherapeutics.com",
    "key_executives": [
        {
            "name": "Mir Imran",
            "position": "CEO"
        },
        {
            "name": "Frank B. W. Oppenheimer",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oral Delivery Systems",
            "products": [
                "Rani Pill"
            ]
        }
    ],
    "seo": {
        "meta_title": "Rani Therapeutics | Innovative Oral Drug Delivery Solutions",
        "meta_description": "Explore Rani Therapeutics, a pioneering biopharmaceutical company developing the Rani Pill for non-invasive oral delivery of biologic drugs, enhancing patient compliance and treatment accessibility.",
        "keywords": [
            "Rani Therapeutics",
            "Biopharmaceuticals",
            "Oral Delivery",
            "Rani Pill",
            "Drug Delivery Systems"
        ]
    },
    "faq": [
        {
            "question": "What is Rani Therapeutics known for?",
            "answer": "Rani Therapeutics is known for its innovative oral delivery systems that allow biologic drugs to be taken in pill form."
        },
        {
            "question": "Who is the CEO of Rani Therapeutics?",
            "answer": "Mir Imran is the CEO of Rani Therapeutics Holdings, Inc."
        },
        {
            "question": "Where is Rani Therapeutics headquartered?",
            "answer": "Rani Therapeutics is headquartered in San Jose, California, USA."
        },
        {
            "question": "What is the Rani Pill?",
            "answer": "The Rani Pill is an oral delivery system designed to administer biologic drugs safely and effectively via the gastrointestinal tract."
        },
        {
            "question": "When was Rani Therapeutics founded?",
            "answer": "Rani Therapeutics was founded in 2014."
        }
    ],
    "competitors": [
        "ALNY",
        "NVS",
        "PFE",
        "AMGN"
    ],
    "related_stocks": [
        "ABBV",
        "GILD",
        "BMY",
        "MRNA"
    ]
}